{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T01:09:58Z","timestamp":1776474598331,"version":"3.51.2"},"reference-count":25,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ijom.2016.04.010","type":"journal-article","created":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T13:48:09Z","timestamp":1462974489000},"page":"1256-1260","source":"Crossref","is-referenced-by-count":49,"title":["Surgical treatment of osteonecrosis of the jaw with the use of platelet-rich fibrin: a prospective study of 15 patients"],"prefix":"10.1016","volume":"45","author":[{"given":"S.E.","family":"N\u00f8rholt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Hartlev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijom.2016.04.010_bib0130","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2016.04.010_bib0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1634\/theoncologist.2010-0183","article-title":"Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw","volume":"16","author":"Miksad","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.ijom.2016.04.010_bib0140","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2016.04.010_bib0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ijom.2016.04.010_bib0150","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.tripleo.2010.02.020","article-title":"Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study","volume":"110","author":"Scoletta","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.ijom.2016.04.010_bib0155","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jcms.2013.05.038","article-title":"Successful surgical management of osteonecrosis of the jaw due to RANK-ligand inhibitor treatment using fluorescence guided bone resection","volume":"41","author":"Otto","year":"2013","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.ijom.2016.04.010_bib0160","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.joms.2013.12.007","article-title":"Management of antiresorptive osteonecrosis of the jaws with primary surgical resection","volume":"72","author":"Carlson","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2016.04.010_bib0165","doi-asserted-by":"crossref","first-page":"e429","DOI":"10.1016\/j.oooo.2012.08.442","article-title":"Principles of oral surgery for prevention of bisphosphonate-related osteonecrosis of the jaw","volume":"117","author":"Heufelder","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.ijom.2016.04.010_bib0170","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tripleo.2010.04.015","article-title":"The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw","volume":"111","author":"Wilde","year":"2011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.ijom.2016.04.010_bib0175","first-page":"1299","article-title":"The outcome after surgical therapy of bisphosphonate-associated osteonecrosis of the jaw\u2014results of a clinical case series with an average follow-up of 20 months","volume":"18","author":"Stockmann","year":"2014","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.ijom.2016.04.010_bib0180","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0714.2011.01091.x","article-title":"Bisphosphonates-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151 patients","volume":"41","author":"Vescovi","year":"2012","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.ijom.2016.04.010_bib0185","first-page":"151","article-title":"Platelet-rich plasma improves wound healing in multiple myeloma bisphosphonate-associated osteonecrosis of the jaw patients","volume":"26","author":"Coviello","year":"2012","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.ijom.2016.04.010_bib0190","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2174\/138920112800624328","article-title":"In search of a consensus terminology in the field of platelet concentrates for surgical use: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), fibrin gel polymerization and leukocytes","volume":"13","author":"Dohan Ehrenfest","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.ijom.2016.04.010_bib0195","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.bjoms.2014.07.256","article-title":"Leucocyte-rich and platelet-rich fibrin for the treatment of bisphosphonate-related osteonecrosis of the jaw: a prospective feasibility study","volume":"52","author":"Kim","year":"2014","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2016.04.010_bib0200","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1016\/j.tripleo.2005.07.011","volume":"101","author":"Choukroun","year":"2006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.ijom.2016.04.010_bib0205","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.tripleo.2005.07.009","article-title":"Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features","volume":"101","author":"Dohan","year":"2006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.ijom.2016.04.010_bib0210","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.tripleo.2005.07.008","article-title":"Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution","volume":"101","author":"Dohan","year":"2006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.ijom.2016.04.010_bib0215","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws","volume":"65","author":"Advisory Task Force on BRONJ","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2016.04.010_bib0220","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.jcms.2015.07.035","article-title":"Surgical treatment of bisphosphonate-associated osteonecrosis: prognostic score and long-term results","volume":"43","author":"Reich","year":"2015","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.ijom.2016.04.010_bib0225","first-page":"298945","article-title":"Platelet rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw: personal experience and review of the literature","author":"Longo","year":"2014","journal-title":"Int J Dent"},{"key":"10.1016\/j.ijom.2016.04.010_bib0230","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.joms.2013.07.027","article-title":"Management of bisphosphonate-related osteonecrosis of the jaw with a platelet-rich fibrin membrane: technical report","volume":"72","author":"Soydan","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2016.04.010_bib0235","first-page":"961","article-title":"Clinical and histopathological studies using fibrin-rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw","volume":"55","author":"Dinca","year":"2014","journal-title":"Rom J Morphol Embryol"},{"key":"10.1016\/j.ijom.2016.04.010_bib0240","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.tripleo.2005.07.012","article-title":"Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part V: histologic evaluations of PRF effects on bone allograft maturation in sinus lift","volume":"101","author":"Choukroun","year":"2006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.ijom.2016.04.010_bib0245","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2147\/CLEP.S71796","article-title":"Existing data sources for clinical epidemiology: Scandinavian Cohort for osteonecrosis of the jaw\u2014work in progress and challenges","volume":"7","author":"Schiodt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ijom.2016.04.010_bib0250","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jcms.2012.01.005","article-title":"Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients","volume":"40","author":"Voss","year":"2012","journal-title":"J Craniomaxillofac Surg"}],"container-title":["International Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0901502716300236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0901502716300236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T04:25:13Z","timestamp":1536726313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0901502716300236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0901502716300236"],"URL":"https:\/\/doi.org\/10.1016\/j.ijom.2016.04.010","relation":{},"ISSN":["0901-5027"],"issn-type":[{"value":"0901-5027","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}